NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Alleviant Medical

Alleviant Medical

Private
Austin, TexasHealthcare & Life Scienceshttps://alleviantmedical.com/

Last Round

VC Round

Jan 14, 2025

Est. Valuation

$113M

Total Funding Raised

$75.9M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Alleviant Medical is a medical device company developing a minimally invasive, no-implant interatrial shunt system for the treatment of chronic heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

interatrial shuntno-implant atrial shuntheart failure devicetranscatheter therapyno-implant heart failure treatmentchronic heart failuremedtechminimally invasive therapyleft atrial decompressionHFpEFHFrEFinterventional cardiologyradiofrequency ablationFDA breakthrough deviceclinical stage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alleviant Medical Comparables

Compare Alleviant Medical with similar companies based on industry and business-model similarity.

Alleviant Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Alleviant Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 14, 2025
Series AJan 26, 2023
GrantSep 1, 2022
View all Funding Rounds

Key People

Founding team and executive leadership

Jacob Kriegel

Co-Founder CMO

Founding Team

Alleviant Medical Investors

Notable investors and investment history

Alleviant Medical investors
InvestorRounds
Omega FundsVC Round
NIH RADxGrant
Gilmartin CapitalVC Round, Series A
Gilde HealthcareVC Round
RiverVest Venture PartnersVC Round, Series A
Vensana CapitalVC Round, Series A
Texas Medical CenterVC Round, Series A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 119% MoM.

  • Jan 14, 2025

    $90M raised in early funding.

View all signals

Alleviant Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alleviant Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alleviant Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range59
Year Founded2017
Last FundingJan 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.